196 related articles for article (PubMed ID: 1435470)
1. Prospective audit of an aminoglycoside consultative service in a general hospital.
Li SC; Ioannides-Demos LL; Spicer WJ; Spelman DW; Tong N; McLean AJ
Med J Aust; 1992 Sep; 157(5):308-11. PubMed ID: 1435470
[TBL] [Abstract][Full Text] [Related]
2. Prospective audit of aminoglycoside usage in a general hospital with assessments of clinical processes and adverse clinical outcomes.
Li SC; Ioannides-Demos LL; Spicer WJ; Berbatis C; Spelman DW; Tong N; McLean AJ
Med J Aust; 1989 Aug; 151(4):224-32. PubMed ID: 2761465
[TBL] [Abstract][Full Text] [Related]
3. Cost savings associated with use of gentamicin versus tobramycin.
Schwinghammer TL; Romano MJ; Wing EJ
Am J Hosp Pharm; 1985 Aug; 42(8):1745-9. PubMed ID: 4036972
[TBL] [Abstract][Full Text] [Related]
4. Cost-benefit analysis of an aminoglycoside monitoring service.
Kimelblatt BJ; Bradbury K; Chodoff L; Aggour T; Mehl B
Am J Hosp Pharm; 1986 May; 43(5):1205-9. PubMed ID: 3087162
[TBL] [Abstract][Full Text] [Related]
5. Providing guidelines and education is not enough: an audit of gentamicin use at The Royal Melbourne Hospital.
Leong CL; Buising K; Richards M; Robertson M; Street A
Intern Med J; 2006 Jan; 36(1):37-42. PubMed ID: 16409311
[TBL] [Abstract][Full Text] [Related]
6. Serial pharmacokinetic dosing of aminoglycosides: a community hospital experience.
Hoffa DE
Ther Drug Monit; 1989 Sep; 11(5):574-9. PubMed ID: 2815234
[TBL] [Abstract][Full Text] [Related]
7. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
[TBL] [Abstract][Full Text] [Related]
8. A practical approach enabling staff pharmacists to prospectively review and dose aminoglycoside therapy.
Possidente CJ; Lynch T
Hosp Pharm; 1988 Nov; 23(11):976-8, 981-3. PubMed ID: 10290757
[TBL] [Abstract][Full Text] [Related]
9. Clinical considerations and costs associated with formulary conversion from tobramycin to gentamicin.
Green ER; Chrymko MM; Rozek SL; Kitrenos JG
Am J Hosp Pharm; 1989 Apr; 46(4):714-9. PubMed ID: 2719049
[TBL] [Abstract][Full Text] [Related]
10. Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing.
Dager WE; King JH
Ann Pharmacother; 2006 Jan; 40(1):9-14. PubMed ID: 16332944
[TBL] [Abstract][Full Text] [Related]
11. Impact of voluntary vs enforced compliance of third-generation cephalosporin use in a teaching hospital.
Bamberger DM; Dahl SL
Arch Intern Med; 1992 Mar; 152(3):554-7. PubMed ID: 1546918
[TBL] [Abstract][Full Text] [Related]
12. Suboptimal aminoglycoside dosing in critically ill patients.
Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
[TBL] [Abstract][Full Text] [Related]
13. The aminoglycoside panel: a new approach to monitoring aminoglycoside therapy.
Gorsky JE; Latts JR
Ther Drug Monit; 1983 Jun; 5(2):169-72. PubMed ID: 6879640
[TBL] [Abstract][Full Text] [Related]
14. Drug usage evaluation of aminoglycoside-induced nephrotoxicity in a community hospital.
Wade WE; McCall CY
Hosp Formul; 1990 Oct; 25(10):1092-4, 1096. PubMed ID: 10107391
[TBL] [Abstract][Full Text] [Related]
15. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
Mars RL; Moles K; Pope K; Hargrove P
Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
[TBL] [Abstract][Full Text] [Related]
16. Effect of aminoglycoside-use restrictions on drug cost.
DeTorres OH; White RE
Am J Hosp Pharm; 1984 Jun; 41(6):1137-9. PubMed ID: 6430070
[TBL] [Abstract][Full Text] [Related]
17. Progressive increase in antibiotic resistance of gram-negative bacterial isolates. Walter Reed Hospital, 1976 to 1980: specific analysis of gentamicin, tobramycin, and amikacin resistance.
Cross AS; Opal S; Kopecko DJ
Arch Intern Med; 1983 Nov; 143(11):2075-80. PubMed ID: 6639227
[TBL] [Abstract][Full Text] [Related]
18. Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin.
Smith CR; Lipsky JJ; Laskin OL; Hellmann DB; Mellits ED; Longstreth J; Lietman PS
N Engl J Med; 1980 May; 302(20):1106-9. PubMed ID: 6988713
[TBL] [Abstract][Full Text] [Related]
19. Aminoglycoside use monitored by clinical pharmaceutical services.
Barriere SL; Conte JE
Am J Hosp Pharm; 1979 Sep; 36(9):1209-11. PubMed ID: 495621
[TBL] [Abstract][Full Text] [Related]
20. Impact of altered aminoglycoside volume of distribution on the adequacy of a three milligram per kilogram loading dose. Critical Care Research Group.
Dorman T; Swoboda S; Zarfeshenfard F; Trentler B; Lipsett PA
Surgery; 1998 Jul; 124(1):73-8. PubMed ID: 9663254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
